//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
pharmaphorum.com, and its magazine Deep Dive, is a leading online destination for pharmaceutical industry and healthcare news, insight, and debate
pharmaphorum
Loading...
#MSD's #tulisokibart has become the first anti-TL1A #antibody to help patients with a type of #inflammatoryboweldisease (IBD) achieve clinical #remission in a phase 3 trial. buff.ly/8KAfDwW
In today’s news: pharmaphorum.com/news #news #pharma #lifesciences #pharmanews #pharmaindustry
#AbbVie has announced its biggest #acquisition since the $63 billion mega-merger with Allergan in 2020, agreeing to take control of #immunology specialist #ApogeeTherapeutics in a $10.9 billion deal.
#Genpact and analyst firm #HFSResearch have published a new #globalstudy that identified four interconnected #enterprisedebts preventing organisations from unlocking their true #AIvalue. pharmaphorum.com/news/genpact...
The R&D baton at #Sanofi will soon be handed over, as the company's global head of R&D, #HoumanAshrafian, departs to take up an as-yet undisclosed opportunity outside the company. pharmaphorum.com/news/sanofi-...
#BoehringerIngelheim is stepping up its push into #oncology with new #clinicaltrials for the pathfinder product #Hernexeos and experimental drug #obrixtamig in hard-to-treat #cancers. buff.ly/WD04dYO
In the first piece of news from the #BIOInternationalConvention, #InsilicoMedicine has teamed up with #SKBiopharmaceuticals on a wide-ranging #partnership to use #AI to find #neuroimmune drug candidates for #centralnervoussystem diseases. pharmaphorum.com/news/insilic...
In a landmark decision for people with early #type1diabetes (T1D) in the #UK, #Sanofi's first-of-its-kind therapy #Tzield, which can delay progression of the disease, has been given a green light for use by the #NHS. buff.ly/jPGDv2U
#CARSgenTherapeutics has claimed approval in #China, its home market, for satricabtagene autoleucel (#satricel), said to be the first #CARTtherapy to be approved anywhere in the world to treat a #solidtumour. pharmaphorum.com/news/carsgen...
38m
In today’s news: pharmaphorum.com/news #news #pharma #lifesciences #pharmanews #pharmaindustry
3d
21h
1d
Video
1d
22h
2h
1d
3h
20h
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
pharmaphorum
Genpact and analyst firm HFS Research recently published a new global study identifying four enterprise debts.
pharmaphorum.com
Genpact finds $18tn in trapped AI value
buff.ly
AbbVie has announced its biggest acquisition since the $63 billion merger with Allergan, buying Apogee and its 'mega-blockbuster' immunology pipeline.
AbbVie climbs post-Allergan M&A peak with Apogee buy
pharmaphorum.com
Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.
Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance
Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houman Ashrafian as Sanofi's R&D head on 1st September.
pharmaphorum.com
Sanofi names ex-Roche exec Fontoura as R&D chief
CARSgen Therapeutics has claimed approval in China for gastric cancer therapy satri-cel, the first CAR-T to be cleared for a solid tumour.
CARSgen bags world-first approval for solid tumour CAR-T
pharmaphorum.com
Video